@PathologyPati
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Product Development New England, Naveris, NavDx, minimal residual disease monitoring in head and neck cancer
Hartford, CT
Joined September 2018
- Tweets13.9K
- Following5.3K
- Followers1.6K
- Likes54.9K
Pat Adams retweeted
This is an extraordinarily dangerous proposal.
The White House is playing politics with critical research into devastating illnesses like cancer, Alzheimer’s, and heart disease. Funding for life-saving biomedical research should never– ever– be subject to political litmus tests.
Breaking News: Federal officials are drafting an executive order that would help cement President Trump’s ability to control billions of dollars in scientific grants funded by the National Institutes of Health. nyti.ms/4yhi6RS
Pat Adams retweeted
A new in vitro system can stimulate the production of cells that resemble human #GerminalCenter B cells, which could assist efforts to study immune responses to #vaccines. Learn more in Science #Immunology: scim.ag/4xtAmqg
Pat Adams retweeted
🧬 New from the Basu Lab! A new @AHNS infographic explores HPV/p16 discordance in oropharyngeal cancer and current guidelines for confirmatory HPV testing.
Prepared by @MollyEHeftNeal and @basulab1.
#AHNS #HPV #HeadAndNeckCancer
Pat Adams retweeted
"RFK Jr. goes rabidly anti-vaccine in face of measles outbreak "
What do you mean "goes"
He's been rabidly anti vaccine for decades
eu.usatoday.com/story/opinio…
Pat Adams retweeted
AZT was a massive breakthrough in the treatment of HIV which at that time was a death sentence
AZT based therapy went on to save millions of lives
RFK Jr rewriting history here
Pat Adams retweeted
No, girls vaccinated with diphtheria/tetanus/pertussis (DTP) vaccine did NOT die at 10 times the rate of unvaccinated girls
RFK Jr is wrong AGAIN
As he has been for decades, on everything to do with vaccines
Pat Adams retweeted
Of all RFK Jr's anti science crap..this for me is one of the very very worst
The HPV vaccine is on the way to ELIMINATING CERVICAL CANCER in many countries
And he wants to stop it
For him..even cervical cancer is better than a vaccine
Sick
RFK Jr.: "Gardasil is probably the single worst mass vaccine that we've ever seen. This vaccine targets millions of preteens and teens for whom the risk of dying from cervical cancer is zero. Nobody in their right mind would ever take this vaccine if they actually read the clinical literature."
"Death rates in the Gardasil trials were 37 times the death rates for cervical cancer. Children who take that vaccine, the Gardasil vaccine, are 37 times more likely to die from the vaccine than they are to die from cervical cancer. The problem with Gardasil, like most vaccines, is it was never tested against a true placebo, an inert placebo."
"And the CDC and HHS say, if you don't test it against a true placebo, it's not science. You have no way of gauging whether the injuries you're seeing from the product are being caused by that product, or whether they're just bad, sad coincidences. The entity that is actually performing the study is, and paying for the study, is Merck."
"Merck got to decide which injuries were being caused by Gardasil and which were just bad coincidences. And because it had that power, it just wrote them all off as bad coincidences."
"You can do that when there's no placebo, because the injuries they were seeing in the control group, where the girls were getting aluminum neurotoxins, were identical to the injuries they were getting in the Gardasil group."
"So they said, well, we don't have to report any of these as vaccine injuries. They were able to license something that is insanely dangerous."
Pat Adams retweeted
🧬 It’s encouraging to see 18F-FDG PET/CT showing strong potential for detecting and staging rare kidney cancers like renal medullary carcinoma, where accurate imaging can make a real difference.
Pat Adams retweeted
When conventional methods don’t clearly resolve equivocal findings in HPV+ anal cancer follow-up, ctHPVDNA may offer a reliable alternative. Rafi Kabarriti, MD, shares recent research in an
Industry Expert Theater supported by @NavDxTest.
Mon Sep 28 @ 3 pm, Blue Theater #ASTRO26
Learn more & add this IET to your schedule: bit.ly/4Aq8u8S
Pat Adams retweeted
New in Advances in Radiation Oncology:
FES-PET for staging newly diagnosed invasive lobular carcinoma
Key finding: In a 4-patient case series, FES-PET changed or supported management in all 3 patients who received it. Case 1: occult supraclavicular nodal (SUVmax 3.3) and chest wall avidity (SUVmax 5.4) after NAC and three margin-positive surgeries prompted a 1000 cGy in 5 fraction sequential boost. Case 2: biopsy-confirmed osseous metastases shifted a cT3N3bM0 patient from curative intent to first-line metastatic therapy. Case 3: a negative scan supported proceeding with chest wall RT and RNI. A fourth patient staged with conventional imaging alone went from cT2N1M0 to pT3N3a at surgery.
Why it matters: ILC is a known blind spot for mammography, MRI, and FDG-PET. When occult nodal disease shows up before the plan is locked, it changes volumes, dose, and sometimes intent.
Important caveat: n = 4, retrospective, selection bias in who got scanned, no systematic comparison with conventional imaging, and short follow-up. The SCL node in case 1 was treated based on tracer avidity without pathologic confirmation. FES-PET is NCCN-supported for recurrent or metastatic ILC, not for primary staging.
Bottom line: This is a signal, not a standard. Useful hypothesis-generating data for a real staging gap, but prospective work is needed before upfront FES-PET changes how we stage locally advanced ILC.
doi.org/10.1016/j.adro.2026.…
@ASTRO_org #RadOnc #OncTwitter #BCSM
Pat Adams retweeted
The Jackson Laboratory is a wonderful, collaborative place to pursue basic & translational science. On the faculty job market? I strongly encourage you to consider joining us in Bar Harbor, Maine!
Apply: go.jax.org/276n55
#JAXresearch #JAXstemcellsdev
Pat Adams retweeted
Secretory carcinoma of the breast is a rare (<0.2%) low-grade triple-negative carcinoma defined by the ETV6::NTRK3 fusion.
🔬 Key clues: bubbly eosinophilic secretions, S100+, ER/PR/HER2−, and PAN-TRK positivity.
Remarkably, it occurs from childhood to older age. #breastpath
Pat Adams retweeted
Among #Medicare beneficiaries with #KidneyFailure, enrollment in Medicare Advantage after the 21st Century Cures Act was associated with lower rates of kidney transplant and new wait-listing vs traditional Medicare.
These findings indicate that policy oversight may be needed to monitor access to a high-value treatment as Medicare Advantage enrollment continues to grow among patients with end-stage kidney disease.
ja.ma/3TlCodM
Pat Adams retweeted
Submit your abstract for an opportunity to present at the Molecular Cytopathology Meeting in Naples #MolCytoPath2026
⭐️🧬 Call For Abstracts 🧬⭐️
🔊 Path trainee and junior/early-in-practice pathologists
🔬Submit an abstract for a platform presentation
💗 XV Molecular Cytopathology Meeting on Dec 9-10, 2026, Naples
molecularcytopathology.net/
Deadline: Oct 1
app.concertosrl.net/Public/A…
#MolCytoPath
Pat Adams retweeted
Diagnostic Approach to Sinonasal Small Round Blue Cell Tumors
For the initial immunohistochemical evaluation of sinonasal small round blue cell tumors, a screening panel including AE1/AE3, p40, synaptophysin (Syn), SOX10, CD45, CD99, and desmin may be employed to assess epithelial, neuroendocrine, neural crest/melanocytic, hematolymphoid, and myogenic differentiation.
🤖 Made with AI
Pat Adams retweeted
Nothing to worry about here! We’ve got bigger issues to focus on like…checks notes…chemtrails.
Pat Adams retweeted
The potential to predict breast and prostate cancer up to 8 years before it is diagnosed from blood cell-free DNA methylation patterns
cell.com/cell-genomics/fullt…
Pat Adams retweeted
Geomosaic: a flexible bioinformatics platform integrating complementary metagenomic analyses from sequencing reads to genomes biorxiv.org/content/10.64898…
Pat Adams retweeted
Do you have a passion for pediatric cancer biology? We are looking for a researcher. This person will work with post-doctoral fellows and scientists to coordinate and manage ongoing mouse experiments. Come join us at St. Jude!
Apply here:
stjude.wd1.myworkdayjobs.com…